|
Tobacco Products Scientific Advisory Committee (TPSAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, SAMHSA
|
OD/DPCPSI/ODP
|
TPSAC advises the FDA Commissioner or designee in discharging responsibilities as they relate to the regulation of tobacco products. The Committee reviews and evaluates safety, dependence, and health issues relating to tobacco products and provides appropriate advice, information and recommendations to the Commissioner of Food and Drugs.
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
OD/DPCPSI/ODP, CSR, NCI, NHLBI, NIAAA, NICHD, NIDA, NIDCR, NIEHS, OD/OER
|
Located in the National Institutes of Health (NIH) Office of Disease Prevention, the Tobacco Regulatory Science Program (TRSP) coordinates the trans-NIH collaborative effort with the US Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) to conduct research to support its regulatory activities over tobacco products. Within the framework of the Tobacco Control Act, the NIH and FDA formed an interagency partnership to foster tobacco regulatory research. The NIH has the infrastructure for the solicitation, review, and management of research. The FDA has expertise in tobacco regulatory science and the authority and resources to support research responsive to FDA’s regulatory authority. Support from FDA was used to fund grants and to provide administrative support and oversight to manage Funding Opportunity Announcements (FOA), application review, policy implementation and oversight, and communicating and reporting to a variety of sources.
|
|
Tox21 - Memorandum of Understanding on High Throughput Screening, Toxicity Pathway Profiling, and Biological Interpretation of Findings
|
Research Initiative
|
FDA
|
NIEHS, NCATS
|
This Memorandum of Understanding sets in place mechanisms to strengthen existing collaborations in the research, development, validation, and translation of new and innovative test methods that characterize key steps in toxicity pathways. This includes the exploration of high throughput screening assays and tests using phylogenetically lower animal species as well as high throughput whole genome analytical methods, to evaluate mechanisms of toxicity. Ultimately, the data generated by these new tools is to be provided to risk assessors to use in the protection of human health and the environment. Success is expected to result in test methods for toxicity testing that are more scientifically and economically efficient and models for risk assessment that are more biologically based.
|
|
Training on Implementing Collaborative Care Model for Behavioral Health Conditions in Nurse-Led Safety-Net Clinics.
|
Training Initiative
|
HRSA
|
NIMH
|
NIMH and HRSA are partnering on an initiative to assist the implementation of a Collaborative Care model in nurse-led safety net clinics supported by HRSA.
NIMH is supporting this initiative via a contract to provide training to the 11 2017 HRSA-funded Nurse Education, Practice, Quality and Retention- Interprofessional Collaborative Practice Program: Behavioral Health Integration (NEPQR-IPCP: BHI) awardees who choose to take part in this initiative. Training will be aimed at ensuring awardees implement the IMPACT Collaborative Model of Depression Care with fidelity. The training will be composed of two phases:
Phase I –Establishing and delivering an initial training program for successful implementation of Collaborative Care. All activities up to and including the In-Person Training; Phase II – Providing follow up training and implementation support after the In-Person Training to ensure fidelity of Collaborative Care Delivery.
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee, Work group, Advisory group, or Task Force
|
BARDA, CDC, FDA
|
NIAID
|
The presidential declaration issued at the 2009 EU-US summit called for the creation of “a transatlantic task force on urgent antimicrobial resistance issues focused on appropriate therapeutic use of antimicrobial drugs in the medical and veterinary communities, prevention of both healthcare- and community-associated drug-resistant infections, and strategies for improving the pipeline of new antimicrobial drugs, which could be better addressed by intensified cooperation between us.” The objectives of the Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR) are to increase the mutual understanding of US and EU activities and programs relevant to the antimicrobial resistance issues identified in the declaration in order to deepen the transatlantic dialogue, provide opportunities to learn from each other, and promote information exchange, coordination, and cooperation.
|
|
Trans-NIH American Indian and Alaska Native Health Communications and Information Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
ACL, IHS
|
NIAMS, CC, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/ORWH, OD/OCPL
|
Formed in 2005, the Trans-NIH AI/AN Health Communications and Information Work Group provides a forum for health education and communications staff from National Institutes of Health (NIH) Institutes, Centers, and Offices to share strategies and effective communication approaches to develop and disseminate health information to American Indian and Alaska Native communities. In partnership with the Indian Health Service (IHS) and the Administration on Aging/Administration for Community Living (AoA/ACL), the Work Group conducts outreach to approximately 1,600 IHS Community Health Representatives (CHRs) and 600 AoA/ACL Title VI grantees nationwide through seasonal e-newsletters featuring NIH health information. The e-newsletter, which replaced quarterly hard-copy mailings, features a wide range of health topics and is distributed to IHS CHRs and AoA/ACL grantees that provide services to Native elders. The purpose of the project is to increase awareness among CHRs and Title VI grantees about the availability of free or low-cost, science-based health information for patients and the general public.
|
|
Trans-NIH Structural Birth Defects Working Group (SBDWG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD, NCI, NEI, NHGRI, NHLBI, NIAAA, NIAMS, NIDCD, NIDCR, NIDDK, NIEHS, NINDS
|
The Trans-NIH SBDWG brings together extramural program officials from NIH components whose missions include research into structural birth defects, with the ultimate goal of facilitating advances in our understanding of the etiology, mechanisms, epidemiology, prevention, and treatment of structural birth defects.
|
|
Trans-NIH Tuberculosis (TB) Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD, FIC, NCATS, NCI, NHLBI, NIAAA, NIAID, NIDA, NIGMS, OD/DPCPSI/OAR
|
The TB Working Group provides a forum for sharing information about NIH-specific TB projects, including both ongoing and proposed research, including extramural funding initiatives. In addition, the working group fosters continual open communication about TB research being conducted across NIH and maintains a consistent message about the importance of NIH intramural and extramural TB research. It also provides an avenue for the introduction of new technology programs of interest and importance for TB research (such as the "human on a chip"). The working group invites guests/speakers from outside NIH and convenes invitations for teleconference participation to other US Government agencies including the Centers for Disease Control and Prevention (CDC) and the US Agency for International Development (USAID).
|
|
Transformation of PROWL Survey into Electronic Form.
|
Health Survey
|
FDA
|
NEI, NLM
|
In 2016, the FDA posted the final version of the Patient-Reported Outcomes with Lasik (PROWL) survey instrument developed in collaboration with the National Eye Institute (NEI) and the Department of Defense (DoD). The survey is intended to collect data to help better understand the potential risk of severe problems that can result from LASIK. The NEI is collaborating with the National Library of Medicine (NLM) to recreate the form in an electronic format to allow for incorporation in electronic data capture systems.
The collaboration worked to make the raw data more accessible and deposited in the Biomedical Research Informatics Computing System (Jan 2018).
|
|
Transplant Cancer Match Study
|
Research Initiative
|
HRSA
|
NCI
|
A study linking databases of US transplant recipients, donors, and waitlist candidates to multiple US cancer registries to evaluate the spectrum of cancer risk in transplant recipients.
|